| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 08/07/2008 | WO2008093464A1 Animal having modification in mgat2 gene |
| 08/07/2008 | WO2008063772A9 Resolvin d series and protectin d1 mitigate acute kidney injury |
| 08/07/2008 | US20080188539 Ramipril-amino acid salts |
| 08/07/2008 | US20080188501 retrovirus inhibor; anticarcinogenic, antidiabetic agent, immunosuppressant, autoimmune diseases; 2-{6-[3(R)-Amino-piperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-4-fluoro-benzonitrile; type 2 diabetes mellitus, impaired glucose tolerance, obesity, multiple sclerosis |
| 08/07/2008 | US20080188449 Treatment of Conditions Caused By Calcium Abnormalities |
| 08/07/2008 | US20080188426 Sodium dependent glucose transporter inhibition; hyperglycemia associated diseases; 3-glucopyranosyloxy- 1H-indazole and 1H-pyrazolo[3,4-b]pyridine derivatives |
| 08/07/2008 | US20080188402 Novel heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| 08/07/2008 | US20080187508 Treatment of Golmerular Basement Membrane Disease Involving Matrix Metalloproteinase-12 |
| 08/07/2008 | DE60223151T2 Chinazolinonderivat Quinazolinone derivative |
| 08/07/2008 | DE102006060953A1 Synergistic preparation for treating urinary tract inflammation, e.g. cystitis, contains low molecular hyaluronic acid and another glycosaminoglycan, preferably chondroitin sulfate |
| 08/07/2008 | CA2677061A1 Benzylamine derivative or pharmaceutically acceptable acid addition salt thereof, and use thereof for medical purposes |
| 08/07/2008 | CA2676968A1 The use of alkaline phosphatase in the treatment of reduced renal function |
| 08/06/2008 | EP1953165A1 Aza-substituted spiro derivative |
| 08/06/2008 | EP1953136A1 Derivatives of (-)-venlafaxine and methods of preparing and using the same |
| 08/06/2008 | EP1952823A1 The use of alkaline phosphatase in the treatment of reduced renal function |
| 08/06/2008 | EP1952701A2 Improving longevity and the condition of elderly cats |
| 08/06/2008 | EP1951291A1 Methods of regulating renalase (monoamine oxidase c) |
| 08/06/2008 | EP1385518B1 Benzimidazolone compounds |
| 08/06/2008 | EP1328515B1 Indoline derivatives and their use as 5-ht2 receptor ligands |
| 08/06/2008 | EP1237575B1 Tnf-alpha antagonist and lfa-1 antagonist for treating rheumatoid arthritis |
| 08/06/2008 | EP1173757B1 Diagnosis of human kidney diseases |
| 08/06/2008 | CN101237878A Intralesional treatment of psoriasis |
| 08/06/2008 | CN101237869A Pyridone derivatives for modulating stress-activated protein kinase system |
| 08/06/2008 | CN101237866A Use of thiazole derivatives and analogues in the treatment of cancer |
| 08/06/2008 | CN101235360A Lactic acid galactococcus with urea conversion capability and its domestication method and application |
| 08/06/2008 | CN101235013A Crystallized 1-(3-fluorophenyl)-5-methyl-2-(1H)pyridine and its preparation method composition and application |
| 08/06/2008 | CN101234186A Decocting soup agent and hot drink cake preparation for treating aged kidney asthenia, frequent micturition and etc. diseases |
| 08/06/2008 | CN101234163A Chinese medicine composition, preparation and application thereof |
| 08/06/2008 | CN101234147A Method of preparing total flavones of tropaeolum for injections |
| 08/06/2008 | CN101234146A Traditional Chinese medicine preparation for treating urinary system affection and preparation thereof |
| 08/06/2008 | CN101234130A Application of capparis spinosa in preparing medicaments for treating kidney disease |
| 08/06/2008 | CN101234110A Pharmaceutical composition containing (3R, 2í»R)-3-(2í»-hydroxy-2í»-cyclopentyl-2í»-phenylethoxy) quinuclidine hydrochloride and uses thereof |
| 08/06/2008 | CN101234109A Pharmaceutical composition containing (3R, 2í»S)-3-(2í»-hydroxy-2í»-cyclopentyl-2í»-phenylethoxy) quinuclidine hydrochloride and uses thereof |
| 08/06/2008 | CN101234108A Pharmaceutical composition containing (3S, 2í»R)-3-(2í»-hydroxy-2í»-cyclopentyl-2í»-phenylethoxy) quinuclidine hydrochloride and uses thereof |
| 08/06/2008 | CN101234107A Pharmaceutical composition containing (3S, 2í»S)-3-(2í»-hydroxy-2í»-cyclopentyl-2í»-phenylethoxy) quinuclidine hydrochloride and uses thereof |
| 08/06/2008 | CN100408573C Pyrazole compounds useful as protein kinase inhibitors |
| 08/06/2008 | CN100408085C Snow lotus preparation for treating prostate disease |
| 08/06/2008 | CN100408083C Chinese medicinal composition for treating calculus |
| 08/06/2008 | CN100408078C Medicinal composition for treating hyperplasia of prostate and its preparing method |
| 08/06/2008 | CN100408077C A Chinese traditional medicinal composition used for treatment of nephritis and uraemia |
| 08/06/2008 | CN100408069C Quality control method of oral preparation for yin enriching kidney supplementing |
| 08/06/2008 | CN100407948C A Chinese wolfberry cake and preparation process thereof |
| 08/05/2008 | US7408021 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 08/05/2008 | US7407980 Therapeutic agents for treating central nervous system disorders, incotinence, sexual disorders, NASAL CONGESTION; ALPHA 1 ADRENERGIC AGONISTS; N-[4-(4,5-Dihydro-1H-imidazol-2-ylmethyl)-phenyl]-methanesulfonamide; chemical synthesis by cyclization |
| 08/05/2008 | US7407964 Stable; potent; penetrates cell membranes; effectively hinders cellular apoptosis; Antiinflammatory agents, Ischemic agents, cancer, autoimmune diseases and nervous system disorders. |
| 08/05/2008 | US7407676 Recovering lignans from plants; obtain plant biomass, expose to extraction solvent, separate solid plant material, remove microorganism from extraction solution, recover lignan |
| 08/05/2008 | CA2388470C Use of carbonylamino derivatives against cns disorders |
| 08/05/2008 | CA2353808C Agent for lowering endothelin levels |
| 08/05/2008 | CA2161808C Bmp-11 compositions |
| 08/05/2008 | CA2137378C D-enzyme compositions and methods of their use |
| 07/31/2008 | WO2008090944A1 Spiro-ring compound |
| 07/31/2008 | WO2008090940A1 Pharmaceutical agent comprising dopamine d2-like receptor agonist as active ingredient and screening method |
| 07/31/2008 | WO2008090857A1 COMPOUND, α1 ADRENALINE RECEPTOR ANTAGONIST, AND COMPOSITION |
| 07/31/2008 | WO2008090140A1 Aryloxypropanolamines, methods of preparation thereof and use of aryloxypropanolamines as medicaments |
| 07/31/2008 | WO2008089593A1 Sustained release tamsulosin formulation and producing method |
| 07/31/2008 | WO2008067084A3 Methods for reducing phosphate absorption |
| 07/31/2008 | WO2008051282A3 Crystalline forms of 4-(2-fluorophenyl)-6-methyl-2-(piperazin-1-yl)thieno(2,3-d)pyrimidine |
| 07/31/2008 | WO2003064596A8 Desaturase genes, enzymes encoded thereby, and uses thereof |
| 07/31/2008 | US20080183003 Neuroprotective agents; nitrate-functional, for example 1-amino-3,5-dimethyl-7-nitrateadamantane hydrochloride |
| 07/31/2008 | US20080182994 Crystallization from solvent; removal of impurities |
| 07/31/2008 | US20080182892 Treatment of interstitial cystitis using (6aR, 10aR)-delta-8-tetrahydrocannabinol-11-oic acids |
| 07/31/2008 | US20080182883 e.g. 1-Benzyl-3-pentyl-2-[6-(1H-tetraazol-5-ylmethoxy)-2-naphthyl]-1H-indole; stroke associated with or resulting from atrial fibrillation; thrombolytic agents for prohylaxis of cardiovascular disorders |
| 07/31/2008 | US20080182841 Sustained release bioadhesive carrier such as polycarbophil; coronary antiarrhythmic; local anesthetic; calcium channel blocker; autocoid; antiprostaglandin; nonsteroidal antiinflammatory; cyclooxygenase, thromboxane or leukotriene inhibitor; infertility |
| 07/31/2008 | US20080182829 8Beta-Hydrocarbyl-Substituted Estratrienes As Selectively Active Estrogens |
| 07/31/2008 | US20080182798 Novel effectors of dipeptidyl peptidase IV |
| 07/31/2008 | US20080181966 Modafinil pharmaceutical compositions |
| 07/31/2008 | CA2676208A1 Compound, a1 adrenergic receptor antagonist agent, and composition |
| 07/30/2008 | EP1950563A2 Method for screening for a substance for promoting regeneration of macrophages |
| 07/30/2008 | EP1950224A2 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 07/30/2008 | EP1950223A2 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 07/30/2008 | EP1950201A1 Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors |
| 07/30/2008 | EP1950199A1 Proline derivatives and use thereof as drugs |
| 07/30/2008 | EP1949936A2 Controlled release composition and method of producing the same |
| 07/30/2008 | EP1949914A1 Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies |
| 07/30/2008 | EP1949909A1 Use of Botulinum Toxin Therapy for Treatment of Urge Type Dysfunction |
| 07/30/2008 | EP1948661A1 Pyrazolo[4,3-d]pyrimidin-5-yl)derivative used as pde5 inhibitors |
| 07/30/2008 | EP1948596A2 Soft anticholinergic esters |
| 07/30/2008 | EP1948593A2 Process for the preparation of tamsulosin and related compounds |
| 07/30/2008 | EP1948216A2 Method of treating acute failure with thrombomodulin variant |
| 07/30/2008 | EP1948204A1 System and method for the prevention and treatment of bacterial and fungal infections including urinary tract infections (uti) using a hypohalous acid compositions |
| 07/30/2008 | EP1948175A1 Treatment of the symptoms of bladder irritation |
| 07/30/2008 | EP1948154A1 System and method for the prevention of bacterial and fungal infections including urinary tract infections (uti) using n-halogenated amino acids |
| 07/30/2008 | EP1531817B1 Glycinamide derivatives as raf-kinase inhibitors |
| 07/30/2008 | EP1480993B1 Desaturase genes, enzymes encoded thereby, and uses thereof |
| 07/30/2008 | EP1438034B1 Use of 1-phenyl-3-dimethylaminopropane compounds for treating urinary incontinence |
| 07/30/2008 | EP1366078B1 Ige receptor antagonists |
| 07/30/2008 | EP1144600B1 Akt-3 nucleic acids, polypeptides, and uses thereof |
| 07/30/2008 | CN101232889A Enhancer of the effect of adrenocorticoid, comprising gum arabic |
| 07/30/2008 | CN101230060A Substitutional piperidines |
| 07/30/2008 | CN101229373A Medicine compounds for treating diabetic nephropathy |
| 07/30/2008 | CN101229371A Use of anti-TNFalpha antibodies and another drug |
| 07/30/2008 | CN101229350A Chinese traditional medicine for treating prostatitis |
| 07/30/2008 | CN101229301A Chinese traditional medicine compounds for treating urinary system infection and prostatitis |
| 07/30/2008 | CN101229292A Chinese traditional medicine preparation for treating nephropathy, preparation method and applications thereof |
| 07/30/2008 | CN101229289A Prostate disease capsule and preparing method thereof |
| 07/30/2008 | CN101229275A Compounds used for tonifying the kidney, nourishing the liver and preparing method thereof |
| 07/30/2008 | CN101229238A Chinese traditional medicine preparation for treating prostate disease |
| 07/30/2008 | CN101229194A Medicine for treating gall-stone, nephrolith and lithangiuria, preparing method thereof |
| 07/30/2008 | CN100406459C 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments |
| 07/30/2008 | CN100406454C Pyrazole compounds useful as protein kinase inhibitors. |